Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 11 studies | 29% ± 12% | |
microglial cell | 10 studies | 26% ± 12% | |
astrocyte | 9 studies | 30% ± 11% | |
natural killer cell | 8 studies | 20% ± 4% | |
epithelial cell | 8 studies | 24% ± 7% | |
dendritic cell | 5 studies | 22% ± 9% | |
ciliated cell | 5 studies | 21% ± 6% | |
myeloid cell | 5 studies | 22% ± 5% | |
adipocyte | 5 studies | 22% ± 4% | |
non-classical monocyte | 4 studies | 23% ± 5% | |
endothelial cell | 4 studies | 25% ± 6% | |
CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
hepatocyte | 4 studies | 35% ± 17% | |
glutamatergic neuron | 4 studies | 38% ± 21% | |
monocyte | 4 studies | 24% ± 1% | |
classical monocyte | 3 studies | 20% ± 4% | |
enterocyte | 3 studies | 19% ± 1% | |
retinal pigment epithelial cell | 3 studies | 27% ± 4% | |
mononuclear phagocyte | 3 studies | 21% ± 2% | |
lymphocyte | 3 studies | 24% ± 5% | |
GABAergic neuron | 3 studies | 44% ± 19% | |
goblet cell | 3 studies | 18% ± 3% | |
T cell | 3 studies | 20% ± 3% | |
alveolar macrophage | 3 studies | 28% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1059.51 | 1445 / 1445 | 100% | 33.89 | 183 / 183 |
lung | 100% | 1531.35 | 577 / 578 | 100% | 27.62 | 1154 / 1155 |
stomach | 100% | 1500.27 | 359 / 359 | 100% | 24.42 | 285 / 286 |
intestine | 100% | 2294.12 | 966 / 966 | 100% | 26.95 | 525 / 527 |
liver | 100% | 1522.96 | 226 / 226 | 99% | 29.72 | 402 / 406 |
thymus | 100% | 1748.68 | 653 / 653 | 99% | 26.07 | 599 / 605 |
breast | 100% | 969.92 | 459 / 459 | 99% | 24.67 | 1106 / 1118 |
brain | 99% | 843.65 | 2619 / 2642 | 99% | 15.42 | 699 / 705 |
bladder | 100% | 1055.00 | 21 / 21 | 98% | 18.64 | 492 / 504 |
prostate | 100% | 987.33 | 245 / 245 | 97% | 15.10 | 489 / 502 |
uterus | 100% | 1022.19 | 170 / 170 | 97% | 21.63 | 447 / 459 |
pancreas | 99% | 648.11 | 324 / 328 | 98% | 22.93 | 175 / 178 |
kidney | 100% | 906.82 | 89 / 89 | 92% | 12.38 | 828 / 901 |
skin | 96% | 466.38 | 1733 / 1809 | 89% | 10.30 | 420 / 472 |
adrenal gland | 99% | 670.27 | 256 / 258 | 80% | 7.77 | 184 / 230 |
ovary | 100% | 1145.96 | 180 / 180 | 72% | 7.33 | 309 / 430 |
spleen | 100% | 2191.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.88 | 1 / 1 |
adipose | 100% | 1038.91 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 856.25 | 1321 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 835.02 | 789 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 25.34 | 28 / 29 |
peripheral blood | 96% | 1449.95 | 894 / 929 | 0% | 0 | 0 / 0 |
heart | 90% | 410.63 | 777 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 4.66 | 32 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
GO_0051792 | Biological process | medium-chain fatty acid biosynthetic process |
GO_0051793 | Biological process | medium-chain fatty acid catabolic process |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0005575 | Cellular component | cellular_component |
GO_0005886 | Cellular component | plasma membrane |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0047372 | Molecular function | acylglycerol lipase activity |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0008126 | Molecular function | acetylesterase activity |
GO_0052739 | Molecular function | phosphatidylserine 1-acylhydrolase activity |
GO_0052740 | Molecular function | 1-acyl-2-lysophosphatidylserine acylhydrolase activity |
Gene name | ABHD3 |
Protein name | Abhydrolase domain containing 3, phospholipase Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) |
Synonyms | |
Description | FUNCTION: Phospholipase that may play a role in phospholipids remodeling. May selectively cleave myristate (C14)-containing phosphatidylcholines through its predominant phospholipase 1 activity, cleaving preferentially acyl groups in sn1 position. In parallel, may have a minor phospholipase 2 activity acting on acyl groups in position sn2. In addition to (C14)-containing phosphatidylcholines, may also act on other medium-chain-containing and oxidatively truncated phospholipids. . |
Accessions | Q8WU67 J3QR14 ENST00000578270.5 J3QQR0 ENST00000577891.1 [Q8WU67-2] J3KSP1 ENST00000584464.1 J3KTE1 ENST00000580981.5 ENST00000580477.1 ENST00000289119.7 [Q8WU67-1] |